A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis

Clinical trial NCT06469164 · COMPLETED

Trial details

NCT number: NCT06469164
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Vaginosis

Start date: 2024-07-01
Primary completion: 2025-07-31
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.